Rizhao Brother Pharmaceutical Co.,Ltd.

RIZHAO BROTHER PHARMACEUTICAL CO.LTD is a pharmaceutical raw material enterprise with a total investment of 500 million yuan. It mainly produces phenylfluorenol, mesalazine, and atorvaquinone, with more than 150 employees.

RIZHAO BROTHER PHARMACEUTICAL CO.LTD is located in the beautiful city of Rizhao. Since its establishment in April 2018, it has been committed to exploring new market opportunities in the pharmaceutical field and bringing higher quality of life to society. As a modern pharmaceutical enterprise that produces and develops raw materials such as phenylfluorenol intermediates and mesalazine, Balotel Pharmaceutical is a large-scale and technologically mature research and development production enterprise in China, becoming a leading enterprise in the industry. RIZHAO BROTHER PHARMACEUTICAL CO.LTD, with outstanding innovation capabilities and profound industrial chain accumulation, is determined to make progress, continuously improve product quality and service level, and successfully explore domestic and foreign markets.

The company mainly produces a series of products such as mesalazine, phenylfluorenol, atorvaquinone, montelukast sodium, buvacestan, tigrelor, etc., providing high-quality raw materials for the global pharmaceutical market and meeting the diverse needs of different customers.